INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2016
|
Net Assets |
£199m |
|
Net Assets per share |
519p |
|
Share price |
450p |
|
Total value of unquoted investments |
£21m |
|
Total number of portfolio companies |
82 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
7.6 |
|
Biogen |
6.9 |
|
Regeneron |
6.2 |
|
Genmab |
5.6 |
|
Alexion |
4.6 |
|
Amgen |
4.3 |
|
Ophthotech |
3.6 |
|
Vertex |
3.5 |
|
Biomarin |
3.4 |
|
Gilead |
3.1 |
|
|
----------- |
|
Total |
48.8 |
|
Portfolio Revenue Split |
% NAV |
|
Revenue Generating |
75 |
|
Near Revenue |
3 |
|
No sales in the near term |
22 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
78 |
|
Europe & UK |
22 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
90 |
|
Unquoted |
10 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
10 JUNE 2016